You are here » Home » Companies » Company Overview » Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd.

BSE: 531380 Sector: Health care
NSE: N.A. ISIN Code: INE405H01018
BSE LIVE 09:30 | 02 Dec 82.65 -4.35
(-5.00%)
OPEN

82.65

HIGH

82.65

LOW

82.65

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 82.65
PREVIOUS CLOSE 87.00
VOLUME 5
52-Week high 100.00
52-Week low 30.00
P/E 18.66
Mkt Cap.(Rs cr) 30.17
Buy Price 0.00
Buy Qty 0.00
Sell Price 82.65
Sell Qty 128.00
OPEN 82.65
CLOSE 87.00
VOLUME 5
52-Week high 100.00
52-Week low 30.00
P/E 18.66
Mkt Cap.(Rs cr) 30.17
Buy Price 0.00
Buy Qty 0.00
Sell Price 82.65
Sell Qty 128.00

Centenial Surgical Suture Ltd. (CENTENIALSURGIC) - Chairman Speech

Company chairman speech

CENTENIAL SURGICAL SUTURE LIMITED ANNUAL REPORT 2010-2011 CHAIRMAN'S REPORT Chairman and Managing Director's Report To the Shareholders, Your Directors have pleasure in presenting their Sixteenth Annual Report together with the Audited Accounts of the Company for the year ended March 31, 2011. This is the sixteenth year in the journey of Centenial Surgical Suture Ltd. Our world grows more complex everyday and we encounter increased challenges. The CENTENIAL management and its staff have risen to challenges for more than 16 years, with commitment, hard work and are confident we will continue to do so in the years' ahead. Through all these years, our Company has faced many tough times and enjoyed equal moments of glory. Everything is worth it, if one is able to create lasting values and a strong core. In the past too, there have been sharp swings in business cycles and there will be more of these in the future, though hopefully not of the magnitude and ferociousness we are seeing today. And each time in the past we have come out of the eye of the storm, we have emerged fitter, stronger and the passion for Innovation is vibrant and urgent. We have been able to create a foundation, which is enabling us to overcome challenging times such as now and helping us to adapt to the current situation while retaining our strength to fulfill the long-term vision. Our values always guide us, and our history and heritage as a company, in one word, stands for trust, service and high Quality. Our demanding standards of governance have set us apart, even more, now, and in the future. Clearly investors and employees will appreciate and learn to value and differentiate between organisations like ours that are ethical, honest, well-governed and transparent, and others, for whom governance is a platitude. This is a huge strength, built over time into our genetic coding. It will always stand us in good stead. We are focusing on building strong administrative and support functions and have concurrently invested in systems for financial accounting, accurate billing, objective legal system, strong human resources and excellent Quality. Your company will exploit its strengths in cardio and vascular sutures business and exploring growth opportunities. Clearly the way to succeed in this market is through improved processes and enhanced production of the right Quality. Despite the negativity of growth we are confident that your company will give an encouraging performance during this financial year, with higher sales growth and improved profitability as compared to the previous year. This would have a long lasting positive impact on both yield levels and productivity. We have a brand name which stands for Quality, reliability, commitment and integrity. The CENTENIAL name is pronounced with great deal of respect, in domestic as well as international markets. It has been created through sheer sincere dedication. This makes us believe that it will be long lasting and something we can build further on. In July 2011, our Company completed its 16th year of operations. Market conditions have been challenging. Credit allocation is a factor to contend with. Your Company has been working through this demanding situation to ensure that viable produsts move forward. In some cases, we have been successful. Your Company continues to be impacted adversely by prices. This has resulted in higer accumlation of receviables and with the sale of products at a discounted prices resulting lower sales and profitability. To further your company's growth, the Cardio Vascular products is being given additional impetus. New production lines have been established to increase the production substantially in the comming years. The management of your company is planning to increase the market share of Cardio Vascular products business. Confidence in our products will further accelerate the success rate in the coming years. Considering the challenging business environment your Company's performance can be termed as satisfactory. Vijay Majrekar Chairman and Managing Director

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard